4.7 Article

Structure-activity relationship analysis of novel GSPT1 degraders based on benzotriazinone scaffold and its antitumor effect on xenograft mouse model

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer

Svenja Lier et al.

Summary: Targeted protein degradation is a promising approach for inactivating cancer drivers, and it has been successfully applied in clinical settings. This study focused on developing a MYC PROTAC called MDEG-541, based on the MYC-MAX dimerization inhibitor 10058-F4 derivative 28RH and Thalidomide. The results showed that MDEG-541 could selectively degrade CRBN neosubstrates, including GSPT1/2 and PLK1, and exhibited activity in gastrointestinal cancers.

BIOORGANIC CHEMISTRY (2022)

Article Chemistry, Medicinal

Development of MDM2 degraders based on ligands derived from Ugi reactions: Lessons and discoveries

Bo Wang et al.

Summary: PROTACs have attracted significant interest in academic and pharmaceutical communities for regulating cellular protein homeostasis. A series of MDM2 degraders were designed and synthesized, with WB214 identified as a potent anti-proliferative agent inducing the degradation of MDM2 and p53. Mechanistic studies revealed that WB214 functions as a molecular glue degrading MDM2, and MDM2 was discovered as a novel neo-substrate of the E3 ligase cereblon. Additionally, WB214 could potently degrade GSPT1, leading to the development of a selective degrader for GSPT1 over MDM2.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma

Joshua D. Hansen et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Biochemistry & Molecular Biology

Targeted protein degradation: current and future challenges

Alexander Hanzl et al.

CURRENT OPINION IN CHEMICAL BIOLOGY (2020)

Article Chemistry, Medicinal

Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras

Akshay D. Takwale et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Development of targeted protein degradation therapeutics

Philip P. Chamberlain et al.

NATURE CHEMICAL BIOLOGY (2019)

Article Chemistry, Medicinal

A novel cereblon modulator for targeted protein degradation

Sung Ah Kim et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Chemistry, Medicinal

A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos

Mary E. Matyskiela et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Biotechnology & Applied Microbiology

Induced protein degradation: an emerging drug discovery paradigm

Ashton C. Lai et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Review Chemistry, Multidisciplinary

Small-Molecule PROTACS: New Approaches to Protein Degradation

Momar Toure et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)

Article Multidisciplinary Sciences

A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase

Mary E. Matyskiela et al.

NATURE (2016)

Article Biochemistry & Molecular Biology

The ins and outs of selective kinase inhibitor development

Susanne Mueller et al.

NATURE CHEMICAL BIOLOGY (2015)

Article Multidisciplinary Sciences

Identification of a Primary Target of Thalidomide Teratogenicity

Takumi Ito et al.

SCIENCE (2010)

Article Chemistry, Medicinal

Design, synthesis and identification of novel colchicine-derived immunosuppressant

Dong-Jo Chang et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)

Article Cell Biology

Structural insights into eRF3 and stop codon recognition by eRF1

Zhihong Cheng et al.

GENES & DEVELOPMENT (2009)

Article Chemistry, Medicinal

Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics

Ashley R. Schneekloth et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)